Cargando…
In silico identification of drug target pathways in breast cancer subtypes using pathway cross-talk inhibition
BACKGROUND: Despite great development in genome and proteome high-throughput methods, treatment failure is a critical point in the management of most solid cancers, including breast cancer (BC). Multiple alternative mechanisms upon drug treatment are involved to offset therapeutic effects, eventuall...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989433/ https://www.ncbi.nlm.nih.gov/pubmed/29871693 http://dx.doi.org/10.1186/s12967-018-1535-2 |